Summary: Oncology is the largest investment area for the pharmaceutical industry, as a result there is a great deal of competition between key players and emphasis on speeding time to market. Benedikte Thunes Akre, Scientific Advisor - Oncology at Bristol Myers-Squibb, spoke to Andrea
